SC
CVS icon

Syon Capital’s CVS Health CVS Stock Holding History

Syon Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.25M Sell
21,781
-226
-1% -$20.2K 0.1% 149
2026
Q1 		$1.58M Sell
22,007
-633
-3% -$48.8K 0.08% 186
2025
Q4 		$1.8M Buy
22,640
+1,236
+6% +$97.4K 0.09% 162
2025
Q3 		$1.61M Buy
21,404
+4,190
+24% +$287K 0.09% 154
2025
Q2 		$1.19M Buy
17,214
+5,404
+46% +$354K 0.08% 178
2025
Q1 		$800K Buy
11,810
+4,284
+57% +$256K 0.07% 223
2024
Q4 		$338K Buy
7,526
+247
+3% +$13.9K 0.03% 371
2024
Q3 		$458K Buy
7,279
+834
+13% +$48.7K 0.04% 293
2024
Q2 		$381K Sell
6,445
-5,109
-44% -$320K 0.04% 309
2024
Q1 		$922K Buy
11,554
+834
+8% +$63.7K 0.09% 169
2023
Q4 		$846K Buy
10,720
+3,262
+44% +$232K 0.09% 164
2023
Q3 		$521K Buy
+7,458
New +$528K 0.06% 179

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Syon Capital's CVS Position: Q2 2026 in Review

Syon Capital reduced its CVS Health (CVS) stake by 1% in Q2 2026, selling an estimated $20.2K and leaving 21,781 shares worth $2.25M. The position accounts for 0.1% of the portfolio, ranked #149.

Syon Capital first reported a position in CVS in Q3 2023 and has held it in 12 quarters since. 2,070 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Syon Capital held 21,781 shares of CVS Health worth $2.25M as of Q2 2026.
  • Syon Capital sold 226 CVS Health shares in Q2 2026, an estimated $20.2K.
  • CVS Health made up 0.1% of Syon Capital's portfolio in Q2 2026, its #149 holding.
  • Syon Capital first reported a position in CVS Health in Q3 2023 and has held it in 12 quarters since.
  • 2,070 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.